FDA Class IFDA·Healthcare and labs·September 9, 2026

Baxter recalls 0.9% Sodium Chloride Injection 500 mL bags over fiberglass particles

Some 500 mL bags of 0.9% Sodium Chloride Injection USP in VIAFLEX plastic containers were found to contain particles identified as fiberglass.

What to do

The notice does not give instructions. Read the official notice for details.

Recall details

Product
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
Hazard
Presence of particulate matter: Particulates identified as fiberglass
Units
145,464 500mL bags
Where sold
Natonwide in the USA
FDA classification
Class I · Ongoing
Classified by FDA
September 15, 2026
Recall started
August 17, 2026
FDA enforcement report
September 9, 2026
Identifiers
  • Codes: Lot: Y495523, Y495523A, Exp 31-Oct-2027
  • FDA recall number: D-0849-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case. Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, Made in USA, NDC 0338-0049-03
Reason for recall
Presence of particulate matter: Particulates identified as fiberglass
Classification
Class I (Ongoing)
Distribution
Natonwide in the USA
Quantity
145,464 500mL bags

Related recalls